ME Therapeutics Holdings Inc. (CSE:METX)
Canada · Delayed Price · Currency is CAD 2.270
-0.230 (-9.20%)
At close: Feb 9, 2026
ME Therapeutics Holdings Market Cap
ME Therapeutics Holdings has a market cap or net worth of CAD 68.21 million as of February 9, 2026. Its market cap has increased by 77.06% in one year.
Market Cap
68.21M
Enterprise Value
67.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.27
Market Cap Chart
Since October 12, 2023, ME Therapeutics Holdings's market cap has increased from 14.43M to 68.21M, an increase of 372.67%. That is a compound annual growth rate of 95.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 75.12M | -37.50% |
| Dec 17, 2025 | 120.20M | 19.29% |
| Dec 30, 2024 | 100.76M | 256.37% |
| Dec 29, 2023 | 28.27M | 95.92% |
| Oct 12, 2023 | 14.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 139.77M |
| Medicenna Therapeutics | 68.40M |
| Sharp Therapeutics | 66.17M |
| NurExone Biologic | 61.66M |
| Sernova Biotherapeutics | 52.56M |
| MedMira | 45.61M |
| BriaCell Therapeutics | 35.41M |
| Defence Therapeutics | 35.00M |